PKTX Stock Chart & Stats
$0.01
>-$0.01(-17.96%)
At close: 4:00 PM EST
$0.01
>-$0.01(-17.96%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.01
Previous CloseN/A
Volume47.78K
Average Volume (3M)38.95K
Market Cap
$2.39M
Enterprise Value$2.04M
Total Cash (Recent Filing)$607.00
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta2.03
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding391,580,140
10 Day Avg. Volume19,453
30 Day Avg. Volume38,947
Financial Highlights & Ratios
PEG Ratio0.11
Price to Book (P/B)10.48
Price to Sales (P/S)0.00
P/FCF Ratio-16.08
Enterprise Value/Market Cap0.85
Enterprise Value/Revenue41.82
Enterprise Value/Gross Profit-146.99
Enterprise Value/Ebitda-6.27
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ProtoKinetix News
PKTX FAQ
What was ProtoKinetix Incorporated’s price range in the past 12 months?
ProtoKinetix Incorporated lowest stock price was <$0.01 and its highest was $0.01 in the past 12 months.
What is ProtoKinetix Incorporated’s market cap?
ProtoKinetix Incorporated’s market cap is $2.39M.
When is ProtoKinetix Incorporated’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were ProtoKinetix Incorporated’s earnings last quarter?
Currently, no data Available
Is ProtoKinetix Incorporated overvalued?
According to Wall Street analysts ProtoKinetix Incorporated’s price is currently Overvalued.
Does ProtoKinetix Incorporated pay dividends?
ProtoKinetix Incorporated does not currently pay dividends.
What is ProtoKinetix Incorporated’s EPS estimate?
ProtoKinetix Incorporated’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ProtoKinetix Incorporated have?
ProtoKinetix Incorporated has 391,580,140 shares outstanding.
What happened to ProtoKinetix Incorporated’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of ProtoKinetix Incorporated?
Currently, no hedge funds are holding shares in PKTX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
ProtoKinetix Incorporated
ProtoKinetix, Incorporated is a biotechnology firm engaged in research and development, specializing in the scientific and medical investigation of glycoproteins known as anti-freeze glycoproteins (AFGPs) and anti-aging glycoproteins (AAGPs). These AFGPs are particularly relevant for their commercial potential within the healthcare sector, with a key area of their development involving utilizing AAGPs for the treatment of dry-eye conditions. Their research efforts are bolstered by a collaborative agreement with the University of British Columbia. Originally incorporated in 1999 as RJV Network, Inc., the company adopted its current name, ProtoKinetix, Incorporated, in July 2003. Its operational headquarters are situated in Marietta, Ohio.
GT Biopharma
―
Revelation Biosciences
―
Dermata Therapeutics
―
CERo Therapeutics Holdings
―
Psyence Biomedical
―
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---